{"product_id":"bpc-157-kpv-blend-benefits","title":"BPC-157 ARG + KPV BLEND - Research Grade Peptide","description":"\u003ch3 id=\"bpc-157-arg-kpv-research-grade-dual-peptide-blend\"\u003e\n  \u003cstrong\u003e\n    BPC-157 ARG + KPV Blend\n    \u003cspan style=\"font-size: 12pt; line-height: 115%; font-family: Arial, Helvetica, sans-serif;\"\u003e\n      – Research-Grade Dual-Peptide Preparation\n    \u003c\/span\u003e\n  \u003c\/strong\u003e\n\u003c\/h3\u003e\n \u003cp style=\"margin: 0 0 20px; padding: 16px 18px; color: #c00000; background-color: #fff5f5; border: 1px solid #f0c7c7; border-left: 4px solid #c00000; font-size: 14px; line-height: 1.65;\"\u003e\n    \u003cstrong\u003eFor research purposes only.\u003c\/strong\u003e\n    This product is supplied exclusively for scientific laboratory research and analytical\n    purposes. It is not intended for human or animal use, consumption, clinical use or\n    therapeutic application. It must not be used in any way that contravenes applicable\n    laws or the requirements of the Medicines and Healthcare products Regulatory Agency.\n  \u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n    \u003cstrong\u003e\n      Defined two-component preparation containing BPC-157 L-arginine salt and KPV tripeptide\n    \u003c\/strong\u003e\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003e\n      Standard formulation divided equally between the two declared components unless a product variant expressly states otherwise\n    \u003c\/strong\u003e\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003e\n      BPC-157 ARG defined on this page as the documented 1:2 BPC-157 di-L-arginine salt\n    \u003c\/strong\u003e\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003e\n      KPV defined on this page as the free-acid tripeptide H-Lys-Pro-Val-OH\n    \u003c\/strong\u003e\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003e\n      Supplied as measured dry or lyophilised laboratory material in sealed flip-top headspace vials\n    \u003c\/strong\u003e\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003e\n      Component identity, chromatographic purity, molecular mass, component quantity and blend composition documented in the applicable completed Certificate of Analysis where supplied\n    \u003c\/strong\u003e\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003e\n      Handled and supplied exclusively as a research-use laboratory preparation\n    \u003c\/strong\u003e\n  \u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp style=\"color: #000000; line-height: 1.72;\"\u003e\n  PEP067 is a defined physical mixture containing two chemically distinct peptide-related substances: BPC-157 di-L-arginine salt and the KPV tripeptide. The two components remain separate molecular substances within the preparation and do not form a new single peptide merely because they are combined in the same vial.\n\u003c\/p\u003e\n\n\u003cp style=\"color: #000000; line-height: 1.72;\"\u003e\n  Unless the selected product variant states otherwise, the total declared blend quantity is divided equally between the BPC-157 ARG component and the KPV component. For example, a 20 mg blend contains a nominal declared component allocation of 10 mg BPC-157 ARG and 10 mg KPV.\n\u003c\/p\u003e\n\n\u003cp style=\"color: #000000; line-height: 1.72;\"\u003e\n  The applicable Certificate of Analysis must state whether the declared BPC-157 ARG quantity is expressed as total di-L-arginine salt mass or as BPC-157 parent-peptide equivalent. These are not interchangeable measurement bases because the accompanying L-arginine contributes to the physical mass of the salt.\n\u003c\/p\u003e\n\n\u003cp style=\"color: #000000; line-height: 1.72;\"\u003e\n  Where laboratory dissolution is required, the solvent, buffer, concentration, mixing procedure, material-compatibility controls and storage conditions stated in the applicable Certificate of Analysis, Safety Data Sheet or validated laboratory method should be followed. A universal bacteriostatic-water instruction should not be applied to every peptide, salt form, blend or laboratory preparation.\n\u003c\/p\u003e\n\n\u003cp style=\"color: #000000; line-height: 1.72;\"\u003e\n  Research Scientific Ltd does not provide advice or recommendations concerning dosage, administration or use in humans or animals.\n\u003c\/p\u003e\n\n\u003c!-- IMPORTANT PRODUCT IDENTITY NOTICE --\u003e\n\u003cdiv style=\"\n    box-sizing: border-box;\n    width: 100%;\n    margin: 24px 0;\n    padding: 21px 23px;\n    background: linear-gradient(135deg, #f8f8f8 0%, #eeeeee 100%);\n    border: 1px solid #b8b8b8;\n    border-left: 5px solid #333333;\n    border-radius: 9px;\n    box-shadow: 0 7px 18px rgba(0, 0, 0, 0.07);\n    font-family: Arial, Helvetica, sans-serif;\n  \"\u003e\n  \u003cdiv style=\"\n      margin: 0 0 9px;\n      color: #111111;\n      font-size: 14px;\n      font-weight: 700;\n      line-height: 1.4;\n      letter-spacing: 0.5px;\n      text-transform: uppercase;\n    \"\u003e\n    Important Component Identity Information\n  \u003c\/div\u003e\n\n  \u003cp style=\"\n      margin: 0 0 11px;\n      color: #333333;\n      font-size: 14px;\n      line-height: 1.72;\n    \"\u003e\n    The BPC-157 ARG component on this page is intended to describe\n    \u003cstrong\u003eBPC-157 di-L-arginine salt with a 1:2 peptide-to-L-arginine stoichiometry\u003c\/strong\u003e.\n    The underlying BPC-157 peptide retains the 15-residue sequence:\n    \u003cstrong\u003e\n      Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val\n    \u003c\/strong\u003e.\n  \u003c\/p\u003e\n\n  \u003cp style=\"\n      margin: 0 0 11px;\n      color: #333333;\n      font-size: 14px;\n      line-height: 1.72;\n    \"\u003e\n    The two L-arginine molecules act as salt-forming components and are not covalently appended to the BPC-157 sequence. BPC-157 ARG should therefore not be described as a 16-residue or 17-residue peptide unless independent supplier records establish a genuinely covalent extended sequence.\n  \u003c\/p\u003e\n\n  \u003cp style=\"\n      margin: 0 0 11px;\n      color: #333333;\n      font-size: 14px;\n      line-height: 1.72;\n    \"\u003e\n    The KPV component is defined as\n    \u003cstrong\u003eH-Lys-Pro-Val-OH\u003c\/strong\u003e.\n    This free-acid tripeptide is chemically distinct from\n    \u003cstrong\u003eH-Lys-Pro-Val-NH\u003csub\u003e2\u003c\/sub\u003e\u003c\/strong\u003e,\n    N-acetylated KPV, side-chain-modified KPV and other KPV derivatives.\n  \u003c\/p\u003e\n\n  \u003cp style=\"\n      margin: 0;\n      color: #333333;\n      font-size: 14px;\n      line-height: 1.72;\n    \"\u003e\n    Before publication, the PEP067 Certificate of Analysis should confirm the BPC-157-to-L-arginine stoichiometry, KPV terminal structure, individual component masses, blend ratio, observed molecular masses and any acetate, trifluoroacetate, residual water or formulation ingredients present in the batch.\n  \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c!-- END IMPORTANT PRODUCT IDENTITY NOTICE --\u003e\n\n\u003ch3 id=\"bpc-157-arg-kpv-declared-blend-composition\"\u003e\n  \u003cstrong\u003eDeclared Blend Composition\u003c\/strong\u003e\n\u003c\/h3\u003e\n\n\u003cp style=\"color: #000000; line-height: 1.72;\"\u003e\n  The following table applies where the variant name represents total declared blend content and the two components are included in equal declared amounts. Each Laboratory Pack vial follows the composition shown for its individual vial strength.\n\u003c\/p\u003e\n\n\u003cdiv style=\"width: 100%; overflow-x: auto; margin: 18px 0 24px;\"\u003e\n  \u003ctable style=\"\n      width: 100%;\n      min-width: 850px;\n      border-collapse: collapse;\n      font-family: Arial, Helvetica, sans-serif;\n      font-size: 14px;\n      color: #222222;\n      background: #ffffff;\n      border: 1px solid #c9c9c9;\n    \"\u003e\n    \u003cthead\u003e\n      \u003ctr style=\"background: #202020; color: #ffffff;\"\u003e\n        \u003cth scope=\"col\" style=\"\n            padding: 13px 15px;\n            text-align: left;\n            border: 1px solid #444444;\n          \"\u003e\n          Product Variant\n        \u003c\/th\u003e\n\n        \u003cth scope=\"col\" style=\"\n            padding: 13px 15px;\n            text-align: left;\n            border: 1px solid #444444;\n          \"\u003e\n          Number of Vials\n        \u003c\/th\u003e\n\n        \u003cth scope=\"col\" style=\"\n            padding: 13px 15px;\n            text-align: left;\n            border: 1px solid #444444;\n          \"\u003e\n          Declared Blend per Vial\n        \u003c\/th\u003e\n\n        \u003cth scope=\"col\" style=\"\n            padding: 13px 15px;\n            text-align: left;\n            border: 1px solid #444444;\n          \"\u003e\n          BPC-157 ARG per Vial\n        \u003c\/th\u003e\n\n        \u003cth scope=\"col\" style=\"\n            padding: 13px 15px;\n            text-align: left;\n            border: 1px solid #444444;\n          \"\u003e\n          KPV per Vial\n        \u003c\/th\u003e\n\n        \u003cth scope=\"col\" style=\"\n            padding: 13px 15px;\n            text-align: left;\n            border: 1px solid #444444;\n          \"\u003e\n          Total Blend in Pack\n        \u003c\/th\u003e\n      \u003c\/tr\u003e\n    \u003c\/thead\u003e\n\n    \u003ctbody\u003e\n      \u003ctr\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          5 mg\n        \u003c\/td\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          1\n        \u003c\/td\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          5 mg\n        \u003c\/td\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          2.5 mg\n        \u003c\/td\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          2.5 mg\n        \u003c\/td\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          5 mg\n        \u003c\/td\u003e\n      \u003c\/tr\u003e\n\n      \u003ctr style=\"background: #f7f7f7;\"\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          10 mg\n        \u003c\/td\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          1\n        \u003c\/td\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          10 mg\n        \u003c\/td\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          5 mg\n        \u003c\/td\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          5 mg\n        \u003c\/td\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          10 mg\n        \u003c\/td\u003e\n      \u003c\/tr\u003e\n\n      \u003ctr\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          20 mg\n        \u003c\/td\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          1\n        \u003c\/td\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          20 mg\n        \u003c\/td\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          10 mg\n        \u003c\/td\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          10 mg\n        \u003c\/td\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          20 mg\n        \u003c\/td\u003e\n      \u003c\/tr\u003e\n\n      \u003ctr style=\"background: #f7f7f7;\"\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          50 mg\n        \u003c\/td\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          1\n        \u003c\/td\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          50 mg\n        \u003c\/td\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          25 mg\n        \u003c\/td\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          25 mg\n        \u003c\/td\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          50 mg\n        \u003c\/td\u003e\n      \u003c\/tr\u003e\n\n      \u003ctr\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          5 × 5 mg Laboratory Pack 1\n        \u003c\/td\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          5\n        \u003c\/td\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          5 mg\n        \u003c\/td\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          2.5 mg\n        \u003c\/td\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          2.5 mg\n        \u003c\/td\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          25 mg\n        \u003c\/td\u003e\n      \u003c\/tr\u003e\n\n      \u003ctr style=\"background: #f7f7f7;\"\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          10 × 5 mg Laboratory Pack 2\n        \u003c\/td\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          10\n        \u003c\/td\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          5 mg\n        \u003c\/td\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          2.5 mg\n        \u003c\/td\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          2.5 mg\n        \u003c\/td\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          50 mg\n        \u003c\/td\u003e\n      \u003c\/tr\u003e\n\n      \u003ctr\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          5 × 10 mg Laboratory Pack 3\n        \u003c\/td\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          5\n        \u003c\/td\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          10 mg\n        \u003c\/td\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          5 mg\n        \u003c\/td\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          5 mg\n        \u003c\/td\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          50 mg\n        \u003c\/td\u003e\n      \u003c\/tr\u003e\n\n      \u003ctr style=\"background: #f7f7f7;\"\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          10 × 10 mg Laboratory Pack 4\n        \u003c\/td\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          10\n        \u003c\/td\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          10 mg\n        \u003c\/td\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          5 mg\n        \u003c\/td\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          5 mg\n        \u003c\/td\u003e\n        \u003ctd style=\"padding: 12px 15px; border: 1px solid #d5d5d5;\"\u003e\n          100 mg\n        \u003c\/td\u003e\n      \u003c\/tr\u003e\n    \u003c\/tbody\u003e\n  \u003c\/table\u003e\n\u003c\/div\u003e\n\n\u003cdiv style=\"\n    box-sizing: border-box;\n    margin: 0 0 26px;\n    padding: 16px 18px;\n    color: #333333;\n    background: #f4f4f4;\n    border-left: 4px solid #777777;\n    border-radius: 6px;\n    font-family: Arial, Helvetica, sans-serif;\n    font-size: 13px;\n    line-height: 1.7;\n  \"\u003e\n  \u003cstrong\u003eComposition basis:\u003c\/strong\u003e\n  The values above describe the nominal allocation between the two named components. The batch Certificate of Analysis must state whether BPC-157 ARG is measured as total di-L-arginine salt mass or as BPC-157 parent-peptide equivalent. Any carrier, bulking agent, residual water, counter-ion or other formulation component is additional to the declared peptide content unless expressly stated otherwise.\n\u003c\/div\u003e\n\n\u003c!-- ULTIMATE PREMIUM PRODUCT SECTION --\u003e\n\u003csection aria-labelledby=\"ultimate-bpc-157-arg-kpv-heading\" style=\"\n    box-sizing: border-box;\n    width: 100%;\n    margin: 34px 0;\n    font-family: Arial, Helvetica, sans-serif;\n  \"\u003e\n  \u003cdiv style=\"\n      position: relative;\n      overflow: hidden;\n      box-sizing: border-box;\n      width: 100%;\n      padding: 38px 29px;\n      background:\n        linear-gradient(\n          135deg,\n          #010101 0%,\n          #080808 23%,\n          #222222 53%,\n          #101010 78%,\n          #020202 100%\n        );\n      border: 1px solid #d4af37;\n      border-radius: 18px;\n      box-shadow:\n        0 24px 54px rgba(0, 0, 0, 0.40),\n        0 0 0 1px rgba(212, 175, 55, 0.10),\n        inset 0 1px 0 rgba(255, 239, 170, 0.10),\n        inset 0 0 38px rgba(212, 175, 55, 0.045);\n    \"\u003e\n    \u003cdiv aria-hidden=\"true\" style=\"\n        position: absolute;\n        top: -150px;\n        right: -110px;\n        width: 390px;\n        height: 390px;\n        border-radius: 50%;\n        background:\n          radial-gradient(\n            circle,\n            rgba(255, 231, 145, 0.27) 0%,\n            rgba(212, 175, 55, 0.13) 31%,\n            rgba(212, 175, 55, 0.035) 53%,\n            rgba(212, 175, 55, 0) 74%\n          );\n      \"\u003e\u003c\/div\u003e\n\n    \u003cdiv aria-hidden=\"true\" style=\"\n        position: absolute;\n        bottom: -180px;\n        left: -130px;\n        width: 370px;\n        height: 370px;\n        border-radius: 50%;\n        background:\n          radial-gradient(\n            circle,\n            rgba(212, 175, 55, 0.17) 0%,\n            rgba(212, 175, 55, 0.055) 41%,\n            rgba(212, 175, 55, 0) 74%\n          );\n      \"\u003e\u003c\/div\u003e\n\n    \u003cdiv aria-hidden=\"true\" style=\"\n        position: absolute;\n        top: 0;\n        left: 7%;\n        width: 86%;\n        height: 2px;\n        background:\n          linear-gradient(\n            90deg,\n            rgba(212, 175, 55, 0) 0%,\n            rgba(247, 223, 136, 0.82) 24%,\n            rgba(255, 240, 176, 1) 50%,\n            rgba(247, 223, 136, 0.82) 76%,\n            rgba(212, 175, 55, 0) 100%\n          );\n      \"\u003e\u003c\/div\u003e\n\n    \u003cdiv style=\"position: relative; z-index: 1;\"\u003e\n      \u003cdiv style=\"\n          display: inline-block;\n          margin: 0 0 18px;\n          padding: 8px 15px;\n          color: #f7df88;\n          background:\n            linear-gradient(\n              135deg,\n              rgba(212, 175, 55, 0.16),\n              rgba(212, 175, 55, 0.05)\n            );\n          border: 1px solid rgba(247, 223, 136, 0.74);\n          border-radius: 999px;\n          box-shadow:\n            0 6px 16px rgba(0, 0, 0, 0.25),\n            inset 0 1px 0 rgba(255, 255, 255, 0.07);\n          font-size: 11px;\n          font-weight: 700;\n          line-height: 1.2;\n          letter-spacing: 1.8px;\n          text-transform: uppercase;\n        \"\u003e\n        Premium ULTIMATE Laboratory Specification\n      \u003c\/div\u003e\n\n      \u003ch2 id=\"ultimate-bpc-157-arg-kpv-heading\" style=\"\n          margin: 0;\n          color: #ffffff;\n          font-size: 30px;\n          font-weight: 700;\n          line-height: 1.2;\n          letter-spacing: 0.3px;\n          overflow-wrap: anywhere;\n        \"\u003e\n        \u003cspan style=\"\n            color: #f4d978;\n            text-shadow:\n              0 0 19px rgba(212, 175, 55, 0.25),\n              0 1px 0 rgba(255, 255, 255, 0.10);\n          \"\u003e\n          ULTIMATE\n        \u003c\/span\u003e\n\n        BPC-157 ARG + KPV BLEND\n      \u003c\/h2\u003e\n\n      \u003cp style=\"\n          margin: 9px 0 0;\n          color: #f0d77d;\n          font-size: 13px;\n          font-weight: 700;\n          line-height: 1.5;\n          letter-spacing: 0.8px;\n          text-transform: uppercase;\n        \"\u003e\n        Additional Preparative HPLC Purification, Controlled Blend Composition and More Stringent LPS Testing\n      \u003c\/p\u003e\n\n      \u003cp style=\"\n          margin: 12px 0 0;\n          color: #d8d8d8;\n          font-size: 15px;\n          line-height: 1.72;\n          letter-spacing: 0.1px;\n        \"\u003e\n        A premium laboratory specification incorporating additional preparative high-performance liquid chromatography purification for each peptide component, controlled quantitative blending and a more stringent bacterial endotoxin or lipopolysaccharide testing specification.\n      \u003c\/p\u003e\n\n      \u003cdiv aria-hidden=\"true\" style=\"\n          width: 100%;\n          height: 1px;\n          margin: 26px 0;\n          background:\n            linear-gradient(\n              90deg,\n              rgba(212, 175, 55, 0) 0%,\n              rgba(212, 175, 55, 0.74) 16%,\n              rgba(247, 223, 136, 1) 50%,\n              rgba(212, 175, 55, 0.74) 84%,\n              rgba(212, 175, 55, 0) 100%\n            );\n        \"\u003e\u003c\/div\u003e\n\n      \u003cp style=\"\n          margin: 0;\n          color: #f1f1f1;\n          font-size: 15px;\n          line-height: 1.82;\n        \"\u003e\n        The\n        \u003cstrong style=\"color: #f7df88;\"\u003e\n          ULTIMATE BPC-157 ARG + KPV Blend\n        \u003c\/strong\u003e\n        is our premium research specification for laboratories requiring an enhanced level of component purification, blend-composition control and batch quality assurance. Following their standard synthesis and purification processes, the BPC-157 ARG and KPV components each undergo an additional preparative high-performance liquid chromatography purification stage before controlled blending.\n      \u003c\/p\u003e\n\n      \u003cp style=\"\n          margin: 17px 0 0;\n          color: #f1f1f1;\n          font-size: 15px;\n          line-height: 1.82;\n        \"\u003e\n        The supplementary chromatographic stages are designed to reduce further the level of chromatographically separable deletion sequences, truncated peptides, incompletely deprotected material, incorrectly modified terminal forms, oxidation products and other synthesis-related or process-related impurities.\n      \u003c\/p\u003e\n\n      \u003cp style=\"\n          margin: 17px 0 0;\n          color: #f1f1f1;\n          font-size: 15px;\n          line-height: 1.82;\n        \"\u003e\n        The separately purified components are subsequently combined according to the declared batch composition. The completed ULTIMATE preparation is also assessed against a more stringent bacterial endotoxin or lipopolysaccharide release specification than the Regular range. The analytical method, reporting units, method-suitability controls, acceptance criterion and final batch result should be stated in the applicable Certificate of Analysis.\n      \u003c\/p\u003e\n\n      \u003cdiv style=\"\n          display: flex;\n          flex-wrap: wrap;\n          gap: 14px;\n          width: 100%;\n          margin: 29px 0;\n        \"\u003e\n        \u003cdiv style=\"\n            box-sizing: border-box;\n            flex: 1 1 210px;\n            min-width: 0;\n            padding: 21px;\n            background:\n              linear-gradient(\n                145deg,\n                rgba(36, 36, 36, 0.98),\n                rgba(7, 7, 7, 0.99)\n              );\n            border: 1px solid rgba(212, 175, 55, 0.46);\n            border-radius: 11px;\n            box-shadow:\n              0 10px 24px rgba(0, 0, 0, 0.27),\n              inset 0 1px 0 rgba(255, 255, 255, 0.035);\n          \"\u003e\n          \u003cdiv aria-hidden=\"true\" style=\"\n              width: 36px;\n              height: 3px;\n              margin: 0 0 13px;\n              background:\n                linear-gradient(\n                  90deg,\n                  #b8860b,\n                  #f7df88,\n                  #d4af37\n                );\n              border-radius: 3px;\n            \"\u003e\u003c\/div\u003e\n\n          \u003cdiv style=\"\n              margin-bottom: 8px;\n              color: #d4af37;\n              font-size: 12px;\n              font-weight: 700;\n              line-height: 1.4;\n              letter-spacing: 1px;\n              text-transform: uppercase;\n            \"\u003e\n            Additional Component Purification\n          \u003c\/div\u003e\n\n          \u003cdiv style=\"\n              color: #dddddd;\n              font-size: 13px;\n              line-height: 1.65;\n            \"\u003e\n            BPC-157 ARG and KPV each undergo an additional preparative high-performance liquid chromatography purification stage before final quantitative blending.\n          \u003c\/div\u003e\n        \u003c\/div\u003e\n\n        \u003cdiv style=\"\n            box-sizing: border-box;\n            flex: 1 1 210px;\n            min-width: 0;\n            padding: 21px;\n            background:\n              linear-gradient(\n                145deg,\n                rgba(36, 36, 36, 0.98),\n                rgba(7, 7, 7, 0.99)\n              );\n            border: 1px solid rgba(212, 175, 55, 0.46);\n            border-radius: 11px;\n            box-shadow:\n              0 10px 24px rgba(0, 0, 0, 0.27),\n              inset 0 1px 0 rgba(255, 255, 255, 0.035);\n          \"\u003e\n          \u003cdiv aria-hidden=\"true\" style=\"\n              width: 36px;\n              height: 3px;\n              margin: 0 0 13px;\n              background:\n                linear-gradient(\n                  90deg,\n                  #b8860b,\n                  #f7df88,\n                  #d4af37\n                );\n              border-radius: 3px;\n            \"\u003e\u003c\/div\u003e\n\n          \u003cdiv style=\"\n              margin-bottom: 8px;\n              color: #d4af37;\n              font-size: 12px;\n              font-weight: 700;\n              line-height: 1.4;\n              letter-spacing: 1px;\n              text-transform: uppercase;\n            \"\u003e\n            Enhanced Composition Control\n          \u003c\/div\u003e\n\n          \u003cdiv style=\"\n              color: #dddddd;\n              font-size: 13px;\n              line-height: 1.65;\n            \"\u003e\n            Batch documentation should record the individual component quantities, BPC-157 ARG salt basis, KPV terminal form and final declared blend ratio.\n          \u003c\/div\u003e\n        \u003c\/div\u003e\n\n        \u003cdiv style=\"\n            box-sizing: border-box;\n            flex: 1 1 210px;\n            min-width: 0;\n            padding: 21px;\n            background:\n              linear-gradient(\n                145deg,\n                rgba(36, 36, 36, 0.98),\n                rgba(7, 7, 7, 0.99)\n              );\n            border: 1px solid rgba(212, 175, 55, 0.46);\n            border-radius: 11px;\n            box-shadow:\n              0 10px 24px rgba(0, 0, 0, 0.27),\n              inset 0 1px 0 rgba(255, 255, 255, 0.035);\n          \"\u003e\n          \u003cdiv aria-hidden=\"true\" style=\"\n              width: 36px;\n              height: 3px;\n              margin: 0 0 13px;\n              background:\n                linear-gradient(\n                  90deg,\n                  #b8860b,\n                  #f7df88,\n                  #d4af37\n                );\n              border-radius: 3px;\n            \"\u003e\u003c\/div\u003e\n\n          \u003cdiv style=\"\n              margin-bottom: 8px;\n              color: #d4af37;\n              font-size: 12px;\n              font-weight: 700;\n              line-height: 1.4;\n              letter-spacing: 1px;\n              text-transform: uppercase;\n            \"\u003e\n            More Stringent LPS Testing\n          \u003c\/div\u003e\n\n          \u003cdiv style=\"\n              color: #dddddd;\n              font-size: 13px;\n              line-height: 1.65;\n            \"\u003e\n            The final preparation is assessed against the enhanced ULTIMATE bacterial endotoxin or lipopolysaccharide specification using an applicable product-specific method-suitability assessment.\n          \u003c\/div\u003e\n        \u003c\/div\u003e\n      \u003c\/div\u003e\n\n      \u003cdiv style=\"\n          box-sizing: border-box;\n          padding: 21px 23px;\n          background:\n            linear-gradient(\n              90deg,\n              rgba(212, 175, 55, 0.065),\n              rgba(255, 255, 255, 0.026)\n            );\n          border-top: 1px solid rgba(255, 255, 255, 0.085);\n          border-right: 1px solid rgba(255, 255, 255, 0.085);\n          border-bottom: 1px solid rgba(255, 255, 255, 0.085);\n          border-left: 4px solid #d4af37;\n          border-radius: 8px;\n          box-shadow:\n            inset 0 0 20px rgba(255, 255, 255, 0.014),\n            0 7px 17px rgba(0, 0, 0, 0.14);\n        \"\u003e\n        \u003cdiv style=\"\n            margin-bottom: 8px;\n            color: #f7df88;\n            font-size: 14px;\n            font-weight: 700;\n            line-height: 1.4;\n            letter-spacing: 0.2px;\n          \"\u003e\n          Regular or ULTIMATE?\n        \u003c\/div\u003e\n\n        \u003cdiv style=\"\n            color: #e5e5e5;\n            font-size: 14px;\n            line-height: 1.75;\n          \"\u003e\n          For the majority of routine analytical method development, chromatographic assessment, mass-spectrometry comparison, blend characterisation, reference-material evaluation and general laboratory work, our\n          \u003cstrong style=\"color: #ffffff;\"\u003e\n            Regular research-grade BPC-157 ARG + KPV Blend remains highly suitable\n          \u003c\/strong\u003e\n          and provides an appropriate balance of peptide quality, batch documentation and value. The ULTIMATE option is intended for scientific projects where additional component-level preparative high-performance liquid chromatography purification, enhanced composition control and a more stringent bacterial endotoxin or lipopolysaccharide specification are specifically required.\n        \u003c\/div\u003e\n      \u003c\/div\u003e\n\n      \u003cp style=\"\n          margin: 20px 0 0;\n          color: #aaaaaa;\n          font-size: 11px;\n          line-height: 1.65;\n          letter-spacing: 0.2px;\n        \"\u003e\n        ULTIMATE BPC-157 ARG + KPV Blend remains strictly for scientific laboratory research and analytical use only. It is not intended for human or animal use, clinical use, diagnostic use, pharmacy compounding, self-administration or therapeutic application. Component identity, complete peptide sequences, arginine stoichiometry, KPV terminal structure, chromatographic purity, individual component content, blend ratio, counter-ion content, residual solvents, water content and bacterial endotoxin results are batch-specific and should be confirmed using the applicable completed Certificate of Analysis. Bacterial endotoxin or lipopolysaccharide testing does not constitute sterility testing.\n      \u003c\/p\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/section\u003e\n\u003c!-- END ULTIMATE PREMIUM PRODUCT SECTION --\u003e\n\n\u003ch3 id=\"bpc-157-arg-kpv-blend-level-information\"\u003e\n  \u003cstrong\u003eBlend-Level Chemical and Composition Information\u003c\/strong\u003e\n\u003c\/h3\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n    \u003cstrong\u003eProduct Name:\u003c\/strong\u003e\n    BPC-157 ARG + KPV Blend\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eCatalogue Product Identifier:\u003c\/strong\u003e\n    PEP067\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003ePreferred Technical Description:\u003c\/strong\u003e\n    Defined BPC-157 di-L-arginine salt and KPV free-acid dual-component preparation\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eProduct Type:\u003c\/strong\u003e\n    Physical mixture of two separate peptide-related substances\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eDeclared Standard Allocation:\u003c\/strong\u003e\n    Equal declared component quantities unless the selected product variant states otherwise\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eMass-Basis Requirement:\u003c\/strong\u003e\n    The Certificate of Analysis must state whether BPC-157 ARG is quantified as total di-L-arginine salt mass or as BPC-157 parent-peptide equivalent\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eMolar-Ratio Clarification:\u003c\/strong\u003e\n    Equal declared component masses do not produce equal molar quantities because the two components have different molecular weights\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eSingle Blend CAS Registry Number:\u003c\/strong\u003e\n    Not applicable; component identifiers should be recorded separately\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eSingle Blend Molecular Formula:\u003c\/strong\u003e\n    Not applicable; component formulae should be recorded separately\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eSingle Blend Molecular Weight:\u003c\/strong\u003e\n    Not applicable; component molecular weights should be recorded separately\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eTotal Declared Blend Content:\u003c\/strong\u003e\n    Sum of the declared BPC-157 ARG and KPV component quantities\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eTotal Powder Fill Mass:\u003c\/strong\u003e\n    May exceed the declared component content where a carrier, bulking agent, counter-ion, residual water or other formulation component is present\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003ePhysical Form:\u003c\/strong\u003e\n    Dry or lyophilised laboratory preparation, as stated in the applicable batch Certificate of Analysis\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eAppearance:\u003c\/strong\u003e\n    Refer to the applicable completed batch Certificate of Analysis\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eComponent Purity:\u003c\/strong\u003e\n    Chromatographic purity should be stated independently for BPC-157 ARG and KPV\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eBlend Composition:\u003c\/strong\u003e\n    Individual component quantities and the final ratio should be confirmed using an appropriate quantitative method\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eAnalytical Interpretation:\u003c\/strong\u003e\n    Component identity, chromatographic purity, individual component content, salt stoichiometry, terminal structure, blend ratio, counter-ion content, water content, residual solvents and bacterial endotoxin results are separate analytical measurements and should be interpreted together\n  \u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3 id=\"bpc-157-arg-component-information\"\u003e\n  \u003cstrong\u003eComponent 1: BPC-157 ARG Chemical and Structural Information\u003c\/strong\u003e\n\u003c\/h3\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n    \u003cstrong\u003eComponent Name:\u003c\/strong\u003e\n    BPC-157 ARG\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003ePreferred Technical Description:\u003c\/strong\u003e\n    BPC-157 di-L-arginine salt\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eAlternative Description:\u003c\/strong\u003e\n    Bepecin di-L-arginine salt; Arg-BPC; BPC-157·2L-Arg\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eMaterial Classification:\u003c\/strong\u003e\n    Synthetic BPC-157 pentadecapeptide salt with L-arginine\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eUnderlying Peptide Sequence Length:\u003c\/strong\u003e\n    15 amino-acid residues\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eUnderlying BPC-157 Sequence:\u003c\/strong\u003e\n    H-Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val-OH\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eUnderlying One-Letter Sequence:\u003c\/strong\u003e\n    GEPPPGKPADDAGLV\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eSalt Stoichiometry Used on This Page:\u003c\/strong\u003e\n    One BPC-157 peptide molecule associated with two L-arginine molecules\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eSalt Notation:\u003c\/strong\u003e\n    BPC-157·2L-Arg\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eCovalent-Sequence Clarification:\u003c\/strong\u003e\n    The L-arginine molecules are salt-forming components and are not additional covalently bonded residues in the BPC-157 peptide sequence\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eParent BPC-157 CAS Number:\u003c\/strong\u003e\n    137525-51-0\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eSeparate Salt CAS Number:\u003c\/strong\u003e\n    No separate verified CAS Registry Number should be stated unless it is supported by the supplier and batch documentation for the exact salt form\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eParent BPC-157 Molecular Formula:\u003c\/strong\u003e\n    C\u003csub\u003e62\u003c\/sub\u003eH\u003csub\u003e98\u003c\/sub\u003eN\u003csub\u003e16\u003c\/sub\u003eO\u003csub\u003e22\u003c\/sub\u003e\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eParent BPC-157 Average Molecular Weight:\u003c\/strong\u003e\n    Approximately 1419.56 g\/mol\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eL-Arginine Molecular Formula:\u003c\/strong\u003e\n    C\u003csub\u003e6\u003c\/sub\u003eH\u003csub\u003e14\u003c\/sub\u003eN\u003csub\u003e4\u003c\/sub\u003eO\u003csub\u003e2\u003c\/sub\u003e\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eL-Arginine Average Molecular Weight:\u003c\/strong\u003e\n    Approximately 174.20 g\/mol\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eCalculated Gross Empirical Formula for the Anhydrous 1:2 Salt:\u003c\/strong\u003e\n    C\u003csub\u003e74\u003c\/sub\u003eH\u003csub\u003e126\u003c\/sub\u003eN\u003csub\u003e24\u003c\/sub\u003eO\u003csub\u003e26\u003c\/sub\u003e\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eCalculated Average Formula Mass for the Anhydrous 1:2 Salt:\u003c\/strong\u003e\n    Approximately 1767.96 g\/mol\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eFormula Qualification:\u003c\/strong\u003e\n    The gross salt formula is calculated from one parent BPC-157 molecule and two L-arginine molecules and should only be used where the 1:2 stoichiometry is confirmed for the batch\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eAlternative Stoichiometries:\u003c\/strong\u003e\n    BPC-157 salts containing one or three basic amino-acid equivalents are chemically possible and would have different gross formulae and formula masses\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eNominal Amount Basis:\u003c\/strong\u003e\n    The batch documentation must state whether the declared amount represents total salt mass or BPC-157 peptide-equivalent content\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eSequence Confirmation:\u003c\/strong\u003e\n    The complete 15-residue BPC-157 sequence should be supported by the applicable supplier, synthesis and batch records\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eArginine-Stoichiometry Confirmation:\u003c\/strong\u003e\n    Amino-acid analysis, quantitative assay or another suitable method should support the declared peptide-to-L-arginine relationship\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eMass-Spectrometry Confirmation:\u003c\/strong\u003e\n    Molecular-identity data should be consistent with the BPC-157 peptide component and should be interpreted together with the separate L-arginine and salt-composition data\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eChemical-Form Confirmation:\u003c\/strong\u003e\n    The Certificate of Analysis should distinguish BPC-157 di-L-arginine salt from BPC-157 free acid, acetate, trifluoroacetate, sodium salt and any covalently extended peptide analogue\n  \u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3 id=\"kpv-component-information\"\u003e\n  \u003cstrong\u003eComponent 2: KPV Chemical and Structural Information\u003c\/strong\u003e\n\u003c\/h3\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n    \u003cstrong\u003eComponent Name:\u003c\/strong\u003e\n    KPV\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003ePreferred Chemical Name:\u003c\/strong\u003e\n    L-Lysyl-L-prolyl-L-valine\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eAlternative Names:\u003c\/strong\u003e\n    Lys-Pro-Val; KPV tripeptide; H-Lys-Pro-Val-OH; MSH (11–13)\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eMaterial Classification:\u003c\/strong\u003e\n    Synthetic linear tripeptide\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eSequence Length:\u003c\/strong\u003e\n    Three amino-acid residues\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eComplete Peptide Sequence:\u003c\/strong\u003e\n    H-L-Lys-L-Pro-L-Val-OH\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eThree-Letter Sequence:\u003c\/strong\u003e\n    Lys-Pro-Val\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eOne-Letter Sequence:\u003c\/strong\u003e\n    KPV\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eN-Terminal Structure:\u003c\/strong\u003e\n    Free L-lysine alpha-amino terminus\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eLysine Side-Chain Structure:\u003c\/strong\u003e\n    Free epsilon-amino group\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eC-Terminal Structure:\u003c\/strong\u003e\n    Free L-valine carboxylic acid terminus\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eCyclic or Linear Structure:\u003c\/strong\u003e\n    Linear tripeptide\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eCAS Number:\u003c\/strong\u003e\n    67727-97-3\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003ePubChem Compound Identifier:\u003c\/strong\u003e\n    CID 125672\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eMolecular Formula:\u003c\/strong\u003e\n    C\u003csub\u003e16\u003c\/sub\u003eH\u003csub\u003e30\u003c\/sub\u003eN\u003csub\u003e4\u003c\/sub\u003eO\u003csub\u003e4\u003c\/sub\u003e\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eAverage Molecular Weight:\u003c\/strong\u003e\n    Approximately 342.44 g\/mol\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eFormula Basis:\u003c\/strong\u003e\n    The formula and molecular weight describe the uncountered KPV free-acid structure without acetate, trifluoroacetate, residual water, solvents or formulation excipients\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eKPV Amide Distinction:\u003c\/strong\u003e\n    H-Lys-Pro-Val-NH\u003csub\u003e2\u003c\/sub\u003e is a separate C-terminally amidated compound and should not be represented using the free-acid formula, molecular weight or CAS number stated above\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eN-Acetylated KPV Distinction:\u003c\/strong\u003e\n    Acetyl-KPV and Ac-KPV-NH\u003csub\u003e2\u003c\/sub\u003e contain additional covalent modifications and are separate molecular substances\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eSequence Confirmation:\u003c\/strong\u003e\n    The complete Lys-Pro-Val sequence should be supported by the applicable supplier, synthesis and batch records\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eTerminal-Structure Confirmation:\u003c\/strong\u003e\n    Molecular-identity documentation should confirm the free C-terminal valine carboxylic acid and distinguish it from a C-terminal amide\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eMass-Spectrometry Confirmation:\u003c\/strong\u003e\n    The observed molecular mass should be consistent with the specified H-Lys-Pro-Val-OH structure\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eChemical-Form Confirmation:\u003c\/strong\u003e\n    The applicable Certificate of Analysis should identify whether the supplied KPV is the uncountered free acid, an acetate-containing form, a trifluoroacetate-containing form or another salt presentation\n  \u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3 id=\"bpc-157-arg-kpv-quality-documentation\"\u003e\n  \u003cstrong\u003eBlend Formulation and Quality Documentation\u003c\/strong\u003e\n\u003c\/h3\u003e\n\n\u003cp style=\"color: #000000; line-height: 1.75;\"\u003e\n  ✓\n  \u003cstrong\u003eSeparate component identity\u003c\/strong\u003e\n  – BPC-157 ARG and KPV should each be supported by suitable molecular-identity documentation.\n  \u003cbr\u003e\n\n  ✓\n  \u003cstrong\u003eBPC-157 ARG salt specification\u003c\/strong\u003e\n  – The peptide-to-L-arginine stoichiometry and the basis of the declared component mass should be stated.\n  \u003cbr\u003e\n\n  ✓\n  \u003cstrong\u003eKPV terminal-form specification\u003c\/strong\u003e\n  – The documentation should confirm whether the supplied KPV is H-Lys-Pro-Val-OH or a different terminally modified derivative.\n  \u003cbr\u003e\n\n  ✓\n  \u003cstrong\u003eComponent-specific chromatographic purity\u003c\/strong\u003e\n  – The high-performance liquid chromatography result for each component should be reported independently.\n  \u003cbr\u003e\n\n  ✓\n  \u003cstrong\u003eDefined component quantities\u003c\/strong\u003e\n  – The Certificate of Analysis should state the nominal and, where determined, measured amount of each component.\n  \u003cbr\u003e\n\n  ✓\n  \u003cstrong\u003eBlend-ratio confirmation\u003c\/strong\u003e\n  – The final preparation should be assessed using a quantitative method suitable for the two components and their respective detector-response characteristics.\n  \u003cbr\u003e\n\n  ✓\n  \u003cstrong\u003ePeptide-content documentation\u003c\/strong\u003e\n  – Net peptide or salt content should be distinguished from chromatographic area percentage and total powder fill mass.\n  \u003cbr\u003e\n\n  ✓\n  \u003cstrong\u003eExcipient documentation\u003c\/strong\u003e\n  – Any mannitol, carrier, bulking agent or other formulation ingredient should be identified with its applicable quantity or concentration.\n  \u003cbr\u003e\n\n  ✓\n  \u003cstrong\u003eChemical-form documentation\u003c\/strong\u003e\n  – Acetate, trifluoroacetate, sodium or another counter-ion should be identified for each component where present.\n  \u003cbr\u003e\n\n  ✓\n  \u003cstrong\u003eWater and residual-solvent documentation\u003c\/strong\u003e\n  – Residual water and applicable process solvents should be stated or controlled through the batch specification.\n  \u003cbr\u003e\n\n  ✓\n  \u003cstrong\u003eBacterial endotoxin documentation\u003c\/strong\u003e\n  – The test method, reporting units, method-suitability controls, acceptance criterion and batch result should be recorded.\n  \u003cbr\u003e\n\n  ✓\n  \u003cstrong\u003eSafety Data Sheet\u003c\/strong\u003e\n  – Supplied to support appropriate laboratory handling, storage and regulatory compliance.\n  \u003cbr\u003e\n\n  ✓\n  \u003cstrong\u003eTrackable laboratory delivery\u003c\/strong\u003e\n  – Securely packaged and dispatched using transport controls appropriate to the applicable batch stability and storage specification.\n\u003c\/p\u003e\n\n\u003cdiv style=\"text-align: center;\"\u003e\n  \u003chr style=\"width: 100%; border: 0; border-top: 1px solid #cccccc;\"\u003e\n\u003c\/div\u003e\n\n\u003cp style=\"color: #c00000; line-height: 1.65;\"\u003e\n  \u003cstrong\u003eFor Research Use Only\u003c\/strong\u003e\n  \u003cbr\u003e\n  This product is supplied strictly for scientific research, laboratory analysis and experimental work. It is not intended for human consumption, animal use, clinical use, diagnostic use, pharmacy compounding, self-administration or any form of therapeutic application.\n\u003c\/p\u003e\n\n\u003cdiv style=\"text-align: center;\"\u003e\n  \u003chr style=\"width: 100%; border: 0; border-top: 1px solid #cccccc;\"\u003e\n\u003c\/div\u003e\n\n\u003ch3 id=\"bpc-157-arg-kpv-product-overview\"\u003e\n  \u003cstrong\u003eBPC-157 ARG + KPV Blend Product Overview\u003c\/strong\u003e\n\u003c\/h3\u003e\n\n\u003cp style=\"color: #000000; line-height: 1.75;\"\u003e\n  Our\n  \u003cstrong\u003eBPC-157 ARG and KPV research-grade dual-component preparation\u003c\/strong\u003e\n  is supplied for controlled analytical method development, peptide and salt-form identity assessment, high-performance liquid chromatography evaluation, liquid chromatography–mass spectrometry workflows, blend-composition analysis, impurity profiling, stability investigation, reference-material comparison and other scientific laboratory applications.\n\u003c\/p\u003e\n\n\u003cp style=\"color: #000000; line-height: 1.75;\"\u003e\n  The formulation contains BPC-157 di-L-arginine salt and the KPV free-acid tripeptide as two chemically distinct components. The BPC-157 ARG component comprises the 15-residue BPC-157 peptide associated with two L-arginine molecules, while KPV comprises the defined sequence H-Lys-Pro-Val-OH.\n\u003c\/p\u003e\n\n\u003cp style=\"color: #000000; line-height: 1.75;\"\u003e\n  The calculated gross empirical formula C\u003csub\u003e74\u003c\/sub\u003eH\u003csub\u003e126\u003c\/sub\u003eN\u003csub\u003e24\u003c\/sub\u003eO\u003csub\u003e26\u003c\/sub\u003e and formula mass of approximately 1767.96 g\/mol apply only to an anhydrous BPC-157 di-L-arginine salt containing two L-arginine molecules per BPC-157 molecule. The batch Certificate of Analysis should confirm this stoichiometry before those values are assigned to the supplied material.\n\u003c\/p\u003e\n\n\u003cp style=\"color: #000000; line-height: 1.75;\"\u003e\n  The KPV component is identified by CAS number 67727-97-3, molecular formula C\u003csub\u003e16\u003c\/sub\u003eH\u003csub\u003e30\u003c\/sub\u003eN\u003csub\u003e4\u003c\/sub\u003eO\u003csub\u003e4\u003c\/sub\u003e and average molecular weight approximately 342.44 g\/mol. These identifiers apply to H-Lys-Pro-Val-OH and not to a C-terminally amidated or N-terminally acetylated KPV derivative.\n\u003c\/p\u003e\n\n\u003cp style=\"color: #000000; line-height: 1.75;\"\u003e\n  Because PEP067 is a physical mixture, the blend has no single meaningful molecular formula, component molecular weight or CAS Registry Number. The chemical identifiers and analytical results for each component should be recorded independently, while the final preparation should additionally be assessed for component quantity and declared blend ratio.\n\u003c\/p\u003e\n\n\u003cp style=\"color: #000000; line-height: 1.75;\"\u003e\n  Chromatographic purity should not automatically be interpreted as equivalent to net component content or quantitative blend composition. Different molecular substances may produce different detector responses, so chromatographic peak-area percentages should only be used to calculate a mass ratio where the analytical method, reference standards and response factors are suitable for that purpose.\n\u003c\/p\u003e\n\n\u003cp style=\"color: #000000; line-height: 1.75;\"\u003e\n  A bacterial endotoxin or lipopolysaccharide result does not establish sterility, complete molecular identity, correct salt stoichiometry, KPV terminal structure, blend composition or the absence of every peptide-related and process-related impurity.\n\u003c\/p\u003e\n\n\u003cp style=\"color: #000000; line-height: 1.75;\"\u003e\n  For the majority of routine analytical method development, chromatographic assessment, mass-spectrometry comparison, blend characterisation, impurity profiling and general laboratory work, the\n  \u003cstrong\u003eRegular BPC-157 ARG + KPV Blend remains highly suitable\u003c\/strong\u003e.\n  The premium black-and-gold ULTIMATE option provides additional preparative high-performance liquid chromatography purification for each component, enhanced blend-composition control and a more stringent bacterial endotoxin or lipopolysaccharide testing specification for projects requiring enhanced quality-control parameters.\n\u003c\/p\u003e\n\n\u003cp\u003e\n  \u003ca href=\"https:\/\/researchscientific.co.uk\/coa\/PEP067.pdf\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e\n    View Certificate of Analysis\n  \u003c\/a\u003e\n\u003c\/p\u003e\n\n\u003cp\u003e\n  \u003ca href=\"https:\/\/researchscientific.co.uk\/msds\/PEP067.pdf\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e\n    View Safety Data Sheet\n  \u003c\/a\u003e\n\u003c\/p\u003e","brand":"peptidestore","offers":[{"title":"2mg","offer_id":50256481419602,"sku":"PEP067\/2mg","price":200.98,"currency_code":"GBP","in_stock":false},{"title":"5mg","offer_id":50256481452370,"sku":"PEP067\/5mg","price":301.09,"currency_code":"GBP","in_stock":true},{"title":"10mg","offer_id":50256481485138,"sku":"PEP067\/10mg","price":526.92,"currency_code":"GBP","in_stock":true},{"title":"20mg","offer_id":50256481517906,"sku":"PEP067\/20mg","price":922.1,"currency_code":"GBP","in_stock":true},{"title":"50mg","offer_id":50256481550674,"sku":"PEP067\/50mg","price":1613.68,"currency_code":"GBP","in_stock":true},{"title":"5 x 5mg Lab Pack 1","offer_id":51242306863442,"sku":"PEP067 \/5mg x 5 Lab Pack","price":1254.54,"currency_code":"GBP","in_stock":true},{"title":"10 x 5mg Lab Pack 2","offer_id":51242312106322,"sku":"PEP067 \/5mg x 10 Lab Pack","price":2509.08,"currency_code":"GBP","in_stock":true},{"title":"5 x 10mg Lab Pack 3","offer_id":51242315055442,"sku":"PEP067 \/10mg x 5 Lab Pack","price":2195.5,"currency_code":"GBP","in_stock":true},{"title":"10 x 10mg Lab Pack 4","offer_id":51242322166098,"sku":"PEP067 \/10mg x 10 Lab Pack","price":4391.0,"currency_code":"GBP","in_stock":true},{"title":"5mg - Ultimate","offer_id":54657462075730,"sku":null,"price":385.0,"currency_code":"GBP","in_stock":true},{"title":"10mg - Ultimate","offer_id":54657511981394,"sku":null,"price":595.0,"currency_code":"GBP","in_stock":true},{"title":"20mg - Ultimate","offer_id":54657522401618,"sku":null,"price":975.0,"currency_code":"GBP","in_stock":true},{"title":"50mg - Ultimate","offer_id":54657529708882,"sku":null,"price":1750.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0931\/9769\/7362\/files\/nupex-bpc-157-kpv-blend-benefits-pure-fine-peptide-powder.png?v=1767865780","url":"https:\/\/nupex.co.uk\/products\/bpc-157-kpv-blend-benefits","provider":"Nupex","version":"1.0","type":"link"}